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Understanding genetic variation might reveal the cause of individual susceptibility to a variety of complex diseases such as asthma, diabetes,
and cancer. Current efforts to identify functional DNA variants have essentially been oriented toward single nucleotide polymorphisms (SNPs)
found in coding regions of candidate genes since they have direct impact on the structure and function of the affected proteins. Abnormal
expression of finely regulated genes could also lead to disequilibria in different metabolic pathways and/or biological processes. Thus
investigation of SNPs in the promoter regions (pSNPs) of genes should improve our knowledge of the etiology of complex diseases.
Unfortunately, little is known about the nature and the prevalence of pSNPs. We have analyzed 197 genes targeting the promoter region, arbitrarily
defined as a 2-kb genomic segment upstream of the transcription initiation site, by screening by dHPLC for the presence of SNPs in a worldwide
panel of 40 individuals. As a result 1838 pSNPs were detected, 75% of which modify (by either gain or loss) putative binding sites of known
transcription factors. We also examined the distribution of these pSNPs among features such as conserved regions, repeats, and dinucleotides as
well as Gene Ontology terms. This report supports the functional relevance of several of the pSNPs investigated and suggests a putative impact on
disease susceptibility.
© 2006 Elsevier Inc. All rights reserved.Keywords: Regulatory genetics; Promoter polymorphisms; Complex diseases; GenomicsUnderstanding gene regulation is highly relevant to human
health and genetic diseases. Since protein levels regulate many
biological pathways, abnormalities in gene regulation could
influence biological processes and thus modify disease risk.
Therefore functional polymorphisms in promoter regions of
relevant genes might explain some of the observed interindi-
vidual phenotype variability such as protein levels and might be
associated with common diseases as recently reported [1–7]. In
other words identifying DNA variants that influence gene
expression is an important issue [8].
Until now, the systematic search for functional polymorph-
isms has predominantly been targeting the coding region of⁎ Corresponding author. Fax: +1 514 345 4731.
E-mail address: daniel.sinnett@umontreal.ca (D. Sinnett).
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doi:10.1016/j.ygeno.2006.01.001DNA (coding single nucleotide polymorphisms, or cSNPs),
mainly because cSNPs include missense polymorphisms that
may have a direct effect on protein structure and function.
Polymorphism in promoter sequences (pSNPs) has been studied
less intensively, despite the suggestion that a substantial number
of relevant mutations reside in such regulating regions [9]. In this
regard, Enard et al. [10] reported six times more quantitative
changes than qualitative differences when human and chimpan-
zee brain proteins were compared. We and others have shown
that in approximately 20% of human genes both alleles are not
always expressed at the same level, thus leading to allelic
imbalance [11–13].
This variability might be due to functional polymorphisms in
the promoter regions of the corresponding genes. In this study,
we screened by dHPLC 40 ethnically diverse individuals for
Fig. 1. Distribution of pSNPs among different dinucleotide subtypes. The ratio
of observed over expected number of pSNPs calculated from the frequencies of
various dinucleotides in the sequences is shown on the y axis and the
dinucleotide subtypes are depicted on the x axis.
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identified 1838 pSNPs that were further analyzed using in silico
tools to assess their putative impact on transcription factor
binding sites as well as their distribution with respect to various
genomic sequence features.
Results
Detection of promoter SNPs
A total of 197 genes encoding proteins involved in double-
stranded DNA repair, cell cycle checkpoint, cell metabolism,
xenobiotic biotransformation, etc, (see Supplementary Table
1S), were screened by dHPLC for the presence of SNPs in their
promoter region, arbitrarily defined as a 2.0-kb region upstream
of the start of the first exon. Although regulatory sequences
might be located outside the targeted regions, a recent survey
showed that up to 90% of validated functional cis-regulatory
polymorphisms lie indeed within the first 2 kb [14]. The sample
size (n = 80 chromosomes) allows greater than 98 and 56%
probability to detect allele frequencies of at least 0.05 either
worldwide or within a specific population, respectively. Overall
the screening of approximately 380 kb/individual led to the
identification of 1838 pSNPs, including 865 (47%) that were
already present in the public database (dbSNP build 124).
Details are available as supplementary materials (see Table 2S).
A proportion of these pSNPs (742/1838, 40.4%) was observed
in a single individual (a singleton SNP), suggesting a low
frequency (1/80 or 0.0125). When we analyzed the distribution
of the pSNPs in respect to the different types of base
substitution we found that transitions (1077 SNPs, 59%)
outnumbered transversions (600 SNPs, 33%); the remaining
9% constituted insertions and deletions (Table 1). The observed
ratio of transition to transversion of 1.8 is similar to that
reported for 5′UTRs [15].
Distribution of pSNPs according to the sequence context
The high frequency of C → T and G → A transitions
supports the role of 5-methylcytosine deamination in the
generation of DNA variability in promoter regions. Thus we
looked at the distribution of the pSNPs among the differentTable 1
Distribution of pSNPs according to the type of nucleotide substitution
Type of nucleotide substitution Number of pSNPs
Transitions G→ A 310
A→ G 225
C → T 355
T→ C 180
Transversions C → A 70
A→ C 55
G→ T 75
T→ G 65
T→ A 52
A→ T 55
C → G 120
G→ C 100types of dinucleotides (Fig. 1), particularly because CpGs are
known to be prone to point mutations. We indeed observed the
highest number of pSNPs in CG dinucleotides, but we did not
observe the expected 10-fold greater mutation rate [16–18].
This pattern could be explained at least partly by the presence of
CG dinucleotides in CpG islands that would be less likely to
mutate (e.g., [15,18]).
Although the observed pSNPs were equally distributed over
the 2-kb region, we found an excess of small inter-SNP distances
(Fig. 2), suggesting a local clustering. Using the human/mouse
alignments (human build 32 vs mouse build 32), we found 3.16
pSNP/kb among conserved regions compared to the overall rateFig. 2. Distribution of the frequencies of distances between SNPs. The
distribution was estimated from 1087 distances from over 121 genes. Since the
mutation events follow a Poisson process, the spatial distribution of the
mutations should follow an exponential distribution if the events are totally
independent, because it is the only memoryless random distribution. The spatial
distribution could also follow a Gamma distribution, which is a general type of
statistical distribution that arises naturally in processes for which the waiting
times between Poisson distributed events are relevant. Hence, if mutations have
an effect on one another at the level of their location, the Gamma distribution
would be more appropriate. The Exponential probability distribution function is
P(x) = λe−λx, where λ is the mutation rate. The Gamma probability distribution
function is P(x) =
xa  1 d e
x
h
CðaÞd ha , where α determines the shape and θ = 1/λ
determines the skewness of the curve. The α parameter is less straightforward to
find.
Fig. 3. Distribution of pSNPs among repetitive elements. The ratio of observed
over expected number of pSNP in different repeat families is shown on the y
axis, whereas the nature of the repeat family is depicted on the x axis. The
distribution of pSNPs was significantly different among the following repeat
families: LTR/ERVK (p = 0.01), LTR/ERVL and LTR/ERB1 (p b 0.001), simple
repeat (p = 0.03), SINE/MIR (p = 0.02).
Fig. 4. Distribution of the density of polymorphic sites in the promoter regions
investigated. The number of polymorphisms per kilobase in the observed data is
shown along with a Poisson distribution curve of λ = 4.75, which is the average
number of SNPs/kb over all genes. The second distribution curve is a double
Poisson distribution in which 46% comes from a Poisson distribution of λ = 2.6
and 54% comes from a Poisson distribution of λ = 5.5. The equation of this
second curve is P(x) = [a × ((λ1
X × e−λ1)/x!)] + [(1 − a) ((λ2X × e−λ2)/x!)] where
a = 0.46; λ1 = 2.6, λ2 = 5.5. The double Poisson distribution fits significantly
better (p b 0.0001) than the simple Poisson distribution (R2 = 0.98). The four
genes with the highest mutation rates are, in decreasing order, GSTM1, MICA,
GPX4, and LILRB4.
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the pSNPs with respect to different types of repeats, we found a
significant overrepresentation of polymorphisms particularly
among the LTR/ERV family of repeats (Fig. 3).
Nucleotide diversity
In promoter regions we observed on average 1 SNP per 204
bp. Nucleotide diversity π was estimated according to
Watterson [19]: the number of segregating sites in genetic
models without recombination from the observed number of
nucleotide substitutions S, adjusted for the sample size n and
the length of the segment L, where S ¼ HPn  1i ¼ 1 1i and π = θ/
L. We calculated a π value of 10 × 10−4, indicating an average
of 1 heterozygous site per kilobase in a diploid genome. This
figure is consistent with those reported by Fan et al. [23] in
expressed sequence tags (π = 5.4 × 10−4), by Freudenberg-Hua
et al. [20] (π = 4.8 × 10−4) for noncoding regions, and by
Cargill et al. [21] (π = 10.0 × 10−4) and Wong et al. [22]
(π = 11.9 × 10−4) for synonymous substitution in coding
sequences [23].
Predicted impact of pSNPs on transcription factor binding sites
(TFBSs)
In the search for pSNPs with putative functional impact, the
proximal promoter regions of the selected genes were screened
for the presence of predicted TFBSs. Following the mapping of
SNPs in the corresponding promoter regions, 428 TFBSs (23%)
were predicted to be lost, 428 (23%) to be gained, and 522
(28%) to lead to a combination of losses and gains. Of note, in
certain cases, SNPs affected putative overlapping TFBSs.
Obviously, such consensus binding sites are highly degenerated
and thus most predictions might not be biologically relevant
[24]. It has been suggested that the presence of evolutionarily
conserved sequences in the promoter regions might indicate
putative functional motifs [25]. We found 91 (5%) pSNPs in
regions conserved between mice and humans that fall inpredicted TFBSs. Of note, such comparative analysis has
predictive value only for changes leading to losses of predicted
TFBSs because gains would be specific to human in our study.
Distribution of pSNPs among genes
As described above, in the genes and the human samples
tested we observed an average of 4.9 pSNPs per 1000 bp.
However, some of the investigated promoter regions are
depleted in SNPs, while others seem to have an excess of
SNP (Fig. 4). To assess whether certain genes were more or
less prone to variability because of their expected function we
examined their Gene Ontology (GO) classifications [26]. The
candidate genes participate in a wide range of molecular
functions and biological processes (see supplemental materi-
als). We classified the pSNPs according to functional classes
(ontology groups) and then compared the pSNP contents
between groups (Fig. 5). The analysis of the substitution rates
of the targeted promoter regions with respect to GO terms
indicates that certain functional groups preferentially occur in
sensitive or resistant promoter sequences. In most cases the
sample size in the GO categories was too small to perform
meaningful comparisons but several interesting trends are
observed (see Supplementary Table 3S). For example gene
products that play roles in the cellular defense response (GO:
0006968), hormone activity (GO: 0005179), and oxidative
stress response (GO: 0006979) have significantly higher
nucleotide diversity values compared to other categories
(Table 2). This is consistent with the concept of balancing
selection that is a known selective force affecting genes
involved in the host response to endogenous and/or
exogenous factors [27]. In contrast, molecular basic functions
such as electron transport (GO: 0006118), anti-apoptosis
Fig. 5. Correlation between the prevalence of pSNPs and Gene Ontology
groups. In this scatter plot, the gene groups associated with a lower mutation rate
are depicted at the left and those with higher mutation rate at the right. Only the
categories with at least five genes are shown. A single gene may appear in more
than one GO category (see Table 3S in the supplementary materials). The gene
groups have been sorted by their mean number of SNPs per base pair. The dots
represent this mean number, the boxes are the standard error, and the whiskers
are the 95% confidence interval. Following this sorting, the groups were evenly
separated into three major classes: the low, middle, and high classes. Since there
are 87 gene groups, there are 29 gene groups per class. We then made pair-wise
mean comparisons between gene groups of different classes. The results of these
comparisons have been summarized by three different annotations at the bottom.
The triangles mean that a gene group is significantly different from at least one
gene group of the opposite class (opposite class being low for high and high for
low). The diamonds are for gene groups that are significantly different from at
least 15 groups of the opposite class. Finally, the circles mean that a gene group
is significantly different from at least 1 gene group of the middle class. Circles,
from left to right, Cellular Defense Response, Hormone Activity, Response to
Oxidative Stress, Protein Serine/Threonine Kinase Activity, Electron Transport.
Diamonds, from left to right, Electron Transport, Protein Amino Acid
Phosphorylation, Anti-apoptosis, Rhodopsin-like Receptor Activity, G-Pro-
tein-Coupled Receptor Protein Signaling Pathway, Cell Adhesion, Hormone
Activity. The colored boxes and whiskers represent mutational hot spots (red)
and mutational cold spots (blue) according to Chuang and Li [43]. (For
interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
Table 2
List of Gene Ontology groups associated with significant genetic diversity
differences in promoter sequences
Gene Ontology group Number of genes SNP density (SNP/kb)
Electron Transport 5 2.55
Protein Serine/Threonine
Kinase Activity
4 2.8
Protein Amino Acid
Phosphorylation
10 3.18
Anti-apoptosis 9 3.25
Rhodopsin-like Receptor Activity 11 5.83
G-Protein-Coupled Receptor
Protein Signaling Pathway
12 6.06
Cell Adhesion 5 6.55
Response to Oxidative Stress 6 6.71
Hormone Activity 4 7.19
Cellular Defense Response 4 8.63
Gene Ontology groups with significant differences from at least one group in the
middle class and/or at least 15 in the opposite class (see Fig. 5).
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0003684) were more prevalent in the low nucleotide diversity
genes (Table 2).
Discussion
Now that genomic DNA sequences of mammalian species are
available, one of the main challenges is the understanding of the
mechanisms underlying transcription control. However, our
knowledge of regulatory elements in the human genome is far
from comprehensive. Consequently, no general rules have been
proposed to account for the functional consequences of regu-
latory mutations, particularly those located in promoters, en-
hancers, silencers, and introns. In this study, we assessed the
genetic variability in the proximal promoter regions of appro-
ximately 200 genes and provided an in-depth in silico charac-
terization of the corresponding 1838 pSNPs to improve the
annotation of these regulatory regions. The sequence elements
affecting transcriptional activity may be found within the genesequence or many thousands of bases up- or downstream of the
transcribed region, but we decided to focus our study on the
proximal promoter region defined here as the 2-kb interval
located immediately upstream of the start of transcription. This
decision was supported by studies that provided evidence this
was indeed an important region to study in the search for human
variation affecting gene expression [14,28].
Although the pSNPs were equally distributed over the 2-kb
interval, we observed an apparent local clustering illustrated by
an excess of small inter-SNP distances. This observation could
be explained by many genomic context features that can
influence mutagenesis, including homonucleotide tracts, sites
of potential Z-DNA formation, direct and indirect repeats,
microsatellites, etc. [29–32]. For instance, it has been estimated
that approximately 23% of cSNPs in human genes are C→Tand
G → A transitions in CpG dinucleotides (e.g., [32]). Here as
well, we observed a similar trend supporting the role of 5-
methylcytosine deamination in the generation of DNA variabil-
ity in promoter regions, which is concordant with the slight
overrepresentation of pSNPs in CG dinucleotides. However, the
latter is much lower than the expected 10-fold increased in the
mutation rate [16–18], which could be explained by the presence
of CG dinucleotides in unmethylated CpG islands that would be
less prone to mutations (e.g., [15,18]). With the exception of a
significant overrepresentation of pSNPs among the LTR/ERV
family of repeats we did not find any other strong association
with the sequence features investigated. The majority of ERV
groups colonized our genome at least 25 million years ago [33]
and are nonfunctional due to the accumulation of mutations.
However, some of these ERVs integrated into regulatory regions
have been shown to alter the expression of adjacent genes [34].
In this regard, some authors have suggested that methyl-CG
deamination has evolved as a specific defense against
colonization of the genome by ERVs [35].
With the expectation that regulatory genomic sequences
surrounding genes are large and polymorphisms in these
regions will surely be abundant, the question arises as to how to
select true regulatory SNPs effectively. Promoter regions
contain several predicted TFBSs [36–38] and in some cases
708 D. Sinnett et al. / Genomics 87 (2006) 704–710a combination of several binding sites is required for biological
function [36–40]. We found by in silico methods that 75%
(1374 of 1838) of the pSNPs had a predicted impact on
putative binding sites for known transcription factors. Thus one
of the obvious challenges is to predict accurately the impact of
a SNP on consensus binding sites that are highly degenerate
and found everywhere without functionally interfering with
normal transcription control. To make our predictions more
selective, we applied a phylogenetic footprinting approach
(e.g., [24,25]) that is based on the assumption that functional
sites in promoters should evolve much slower than other
regions that do not bear any conservative function [41]. We
have found 91 pSNPs in human–mouse conserved regions.
However, one should be aware that species-specific regulatory
differences will not be recognized by this method. For instance,
it has recently been shown that 32–40% of human functional
TFBSs are not functional in rodents [42]. Furthermore, this
interspecies comparative approach cannot be applied on pSNPs
leading to predicted gains of TFBSs. We are in the process of
evaluating the effect of each SNP with in vitro methods.
Chuang and Li [43] provided evidence that categories of
functionally related genes reside preferentially in mutationally
sensitive or resistant regions. Here, we showed that some genes
more tolerant to genetic variability were biased toward host
response (receptors, cell adhesion, cellular defense, oxidative
stress response, etc.), whereas the resistant ones were biased
toward essential cellular processes (electron transport, protein
modifications, apoptosis, etc.). These studies taken together
would suggest that certain genes are under selective pressure
against mutations because of their function or these genes are
tightly regulated and therefore alterations in regulatory func-
tions are detrimental to their expression, whereas permissive
groups might reflect genes that need new mutations to face new
stimuli. Akey et al. [44] suggested that these patterns of genetic
variation might represent signatures of natural selection. The
validation of the functional impact of the pSNPs associated with
the tolerant and resistant genes might help us to develop new
tools to identify “true” regulatory SNPs. Because sequence
variation in the regulatory region of the selected genes might
give rise to differences in the gene product's levels, such
variants would be suitable candidates for genetic susceptibility
of complex traits.
Material and methods
Population samples
The population panel consisted of 40 unrelated individuals including
8 Africans, 8 Europeans, 8 Asians, 8 Middle-Easterners, and 8 Amerindians.
This collection constituted genomic DNA samples obtained from Coriell
(GM10469, GM10470, GM10471, GM10492, GM17101, GM17109,
GM17108, GM17310, GM17311, GM17312, GM17314, GM17316,
GM17317, GM17318, GM17319, GM17320) or isolated from peripheral
blood of anonymous donors following informed consent.
SNP detection in promoter regions
The SNP detection was performed by PCR-based dHPLC analysis followed
by direct sequencing. The promoter region arbitrarily defined as the 2-kbsequence upstream of the transcription start site (based on RefSeq mRNA) of
each gene was amplified sequentially in four to eight ∼350-bp overlapping
fragments. Promoter positions were numbered with respect to the first nucleotide
of the first exon as +1 and the nucleotide immediately upstream as −1. The
primer sequences and detailed information on the reaction conditions are
available on request. Briefly, PCR was done in a 50-μl reaction mixture
containing 15 ng DNA, 0.5 μM each primer, 0.12 mM dNTPs, 1.8 mM MgCl2,
1.8 U Platinum Taq(Invitrogen) for 34 cycles using a touchdown approach from
62 to 55°C. dHPLC analysis was performed on a Transgenomic WAVE system
(Transgenomic, Inc.). Briefly, PCR products were denatured for 1 min at 94°C
and then gradually reannealed by decreasing sample temperature to 45°C over a
period of 30 min to form homo- and/or heteroduplexes. The resulting PCR
species were applied to the dHPLC column and eluted with a linear acetonitrile
gradient at a flow rate of 1.5 ml/min. The gradient conditions were determined
using the WaveMaker software (Transgenomic, Inc.). Because the dHPLC
approach is based on the differential retention of homo- and heteroduplex DNA
fragments by ion-pair chromatography under conditions of partial heat
denaturation [45], optimal discrimination of double-stranded combinations
depends on the temperature at which partial denaturation of heteroduplexes
occur. In this study, samples were run at 1 degree above and/or below the
predicted temperature to ensure resolution of most possible sequence variations.
All samples were analyzed by visual inspection by at least two independent
investigators and samples with clear or suggestive variant peaks were
sequenced.
Sequencing
The nature and the position of each pSNP were determined by direct
sequencing using the same primers as used for dHPLC. For most SNPs, it was
possible to evaluate both the forward and the reverse sequences. We carried out
dye terminator sequencing using the ABI Prism Big Dye Systems. Samples were
run on ABI 3700 automated sequencer and analyzed using the Phred/Phrap/
Consed suite of software to provide base quality scores [46]. Polymorphisms
were verified by manual evaluation of the individual sequence traces by two
independent researchers. To be considered valid and of sufficient quality to be
included in our analysis, SNPs must have been identified in sequences with a
Phred Quality Value over 20. In addition, it must have been observed in both
strands or, if only one strand was sequenced, in a least two different DNA
samples.
In silico analysis
(i) Transcription factor binding site identification: Depending on the position
in the regulatory region, a regulatory SNP (pSNP) may lead either to complete
loss of a TF site [47,48] or to the formation of a novel TF site [49,50]. We used
the MatInspector program from Genomatix Software GmbH (Germany) to
determine the presence of putative binding sites for known transcription factors.
For each SNP, major and minor alleles, together with 50 bp of surrounding
sequence, were sent for analysis using the Optimized Matrix Similarity
thresholds. (ii) Analysis of DNA repeats and low-complexity DNA sequences
was done using RepeatMasker (www.repeatmasker.org) with the “speed and
sensitivity” parameter set to “default.” (iii) Gene–GO term associations were
obtained from the Gene Ontology Annotation (www.ebi.ac.uk/GOA) project as
of October 2004. (iv) Dinucleotide analysis was made using only genes with a
completely sequenced 2-kb region (n = 121 genes), thus removing genes with
sequencing gaps. (v) Conserved regions were as defined in the tight human/
mouse alignments (hg16) available from the UCSC Genome Browser database
(version 17).
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